Upload
Featured Recent Articles Topics Login Upload

Search Results for 'metastatic cancer'

metastatic cancer published presentations and documents on DocSlides.

What’s Positive about Triple Negative Breast Cancer
What’s Positive about Triple Negative Breast Cancer
by myesha-ticknor
What’s Positive about Triple Negative Breast Ca...
ADVANCED PROSTATE CANCER: BONE ISSUES AND METASTASES
ADVANCED PROSTATE CANCER: BONE ISSUES AND METASTASES
by min-jolicoeur
ADVANCED PROSTATE CANCER: BONE ISSUES AND METASTA...
Audit of patients diagnosed with colorectal cancer within t
Audit of patients diagnosed with colorectal cancer within t
by giovanna-bartolotta
Clare Westwood. Colorectal Nurse Consultant. Coun...
Cancer Metastasis: Building a framework
Cancer Metastasis: Building a framework
by lois-ondreau
Gaorav. P. Gupta and Joan . Massague. Gabriella ...
DR: Hussein Sabbagh Oncologist / Radiotherapist
DR: Hussein Sabbagh Oncologist / Radiotherapist
by connor899
Epidemiology . https://seer.cancer.gov/statfacts/h...
Alkylating Agents Dr.Muhammad
Alkylating Agents Dr.Muhammad
by seth389
Albaghdadi. Oncologist. HISTORY. Mechlorethamine. ...
Metastatic triple-positive
Metastatic triple-positive
by marcos147
breast. . cancer. . needs. . different. . ther...
Module 9: HER2-Positive and Triple-Negative BC
Module 9: HER2-Positive and Triple-Negative BC
by unita
Percent with Patients. Number of Patients (Median)...
Anti-EGFR induced skin
Anti-EGFR induced skin
by berey
toxicity. ESDO Learning Bytes 2021. Dr Violaine RA...
2 Strengthening shared decision making between
2 Strengthening shared decision making between
by molly
nm. CRPC patients and the healthcare team. GUIDE C...
OHDSI Collaborator Meeting
OHDSI Collaborator Meeting
by eliza
Oncology WG Presentation.  . 12/3/2019. Agenda. I...
GU CONNECT animated video
GU CONNECT animated video
by sophie
Clinical implementation of testing and PARP. i. m...
Module 8: ER-Positive Metastatic
Module 8: ER-Positive Metastatic
by anastasia
Breast Cancer . Elizabeth O’Reilly, MSN, MPH, AN...
Median PFS: 2.6 months (95% CI, 1.7-3.5)
Median PFS: 2.6 months (95% CI, 1.7-3.5)
by ceila
Median PFS: 1.4 months (95% CI, 1.2-1.6) . Median ...
Antibody–Drug Conjugates in Development for Non-
Antibody–Drug Conjugates in Development for Non-
by elizabeth
s. mall Cell . Lung Cancer. , Gastric Cancer, and ...
Released Date Sept 2018
Released Date Sept 2018
by leah
National Cancer Grid EWING SARCOMA – GUIDELINES...
GI cancers: targeted treatments
GI cancers: targeted treatments
by finley
and IO approaches for advanced/metastatic disease....
Palliative Chemotherapy: When is it appropriate?
Palliative Chemotherapy: When is it appropriate?
by jaena
. Mariela Macias, M.D.. Goals and Objectives. Role...
Dawid Sigorski, Ph.D .
Dawid Sigorski, Ph.D .
by morgan
Department. of . oncology. . UWM. Epidemiology. ...
Surgery for Metastatic Brain Tumor from Breast Cancer
Surgery for Metastatic Brain Tumor from Breast Cancer
by bella
Tanat Vaniyapong, MD. Neurosurgery Unit, Faculty o...
NasdaqVERU
NasdaqVERU
by isabella2
VeruInc The Prostate Cancer Company Novel Medicine...
NasdaqVERU
NasdaqVERU
by iris
VeruInc The Prostate Cancer Company Novel Medicine...
CURRICULUM VITAE PROFESSIONAL Current Position Surgical and Nuclear
CURRICULUM VITAE PROFESSIONAL Current Position Surgical and Nuclear
by riley
PUBLICATIONS Peer Reviewed Articles Turmen T Conge...
Module 9: HER2-Positive and
Module 9: HER2-Positive and
by norah
Triple-Negative Breast Cancer. Jamie Carroll, APRN...
CURRICULUM VITAE PROFESSIONAL Current Position: Surgical and Nuclear
CURRICULUM VITAE PROFESSIONAL Current Position: Surgical and Nuclear
by white
PUBLICATIONS Peer Reviewed Articles, Turmen T: Con...
Hormone Receptor Positive Metastatic Breast Cancer
Hormone Receptor Positive Metastatic Breast Cancer
by pamella-moone
. 5/9/2017. The Lancet July 11, 1895. ON THE TRE...
NY-ESO-1 Specific T Cell Therapy for Patients with Metastatic Sarcoma
NY-ESO-1 Specific T Cell Therapy for Patients with Metastatic Sarcoma
by giovanna-bartolotta
Seth M. Pollack, . MD. Associate in Clinical Rese...
Raising the Bar in the Management of Advanced/Metastatic NSCLC
Raising the Bar in the Management of Advanced/Metastatic NSCLC
by debby-jeon
Dr Tan . Jiunn. Liang. Clinical Specialist (Resp...
Sipuleucel -T Survival Benefit
Sipuleucel -T Survival Benefit
by calandra-battersby
Sipuleucel. -T was approved based on HR of 0.775 ...
Radiology Pathology Correlation
Radiology Pathology Correlation
by luanne-stotts
Patient Presentation. Casey Morrison, MS4 Sep...
Metastatic Breast Cancer
Metastatic Breast Cancer
by lindy-dunigan
A sub-focus on specific clinical scenarios. What ...
Metastatic HER2-Positive Breast Cancer: Treatment Selection
Metastatic HER2-Positive Breast Cancer: Treatment Selection
by test
First . Line and Beyond. Moderator:. Joseph Gligo...
Melanoma
Melanoma
by olivia-moreira
Sandy Beam RN, OCN, CCRC. Research Nurse Clinicia...
New Therapies for Metastatic Breast Cancer
New Therapies for Metastatic Breast Cancer
by alexa-scheidler
Sigrun Hallmeyer, MD. Oncology Specialists, SC. D...
Isolated splenic metastases from cervical cancer: a case report
Isolated splenic metastases from cervical cancer: a case report
by remington
Dr . Prakruthi. . Venkatappa. , Radiology Registr...
Current opinions on managing
Current opinions on managing
by queenie
nm. crpc and the implications of new . imaging mod...
1. TUBERCULOSIS 2. CANCER OF THE LUNG
1. TUBERCULOSIS 2. CANCER OF THE LUNG
by cady
Repiratory. block. SECOND . PRACTICAL. Respirator...
Oncological perspective on Invasive lobular carcinoma
Oncological perspective on Invasive lobular carcinoma
by elise
Anne Sofie Brems-Eskildsen. Department of Oncology...
Antibody–Drug Conjugates
Antibody–Drug Conjugates
by wang
in Development for . Breast Cancer. Sara A. Hurvit...
Module 1 Androgen Deprivation Therapy: Clinical Differences
Module 1 Androgen Deprivation Therapy: Clinical Differences
by teresa
Prostate cancer (. PCa. ) is one of the most-commo...